OptimizeRx (OPRX) Capital Expenditures (2016 - 2025)
OptimizeRx's Capital Expenditures history spans 14 years, with the latest figure at -$33000.0 for Q4 2025.
- On a quarterly basis, Capital Expenditures rose 73.17% to -$33000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $58000.0, a 48.21% decrease, with the full-year FY2025 number at $58000.0, down 48.21% from a year prior.
- Capital Expenditures hit -$33000.0 in Q4 2025 for OptimizeRx, down from $54000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for OPRX hit a ceiling of $702000.0 in Q4 2023 and a floor of -$123000.0 in Q4 2024.
- Historically, Capital Expenditures has averaged $74086.3 across 5 years, with a median of $26927.5 in 2022.
- Biggest five-year swings in Capital Expenditures: skyrocketed 60179.88% in 2021 and later crashed 117.52% in 2024.
- Tracing OPRX's Capital Expenditures over 5 years: stood at $301601.0 in 2021, then plummeted by 67.21% to $98893.0 in 2022, then surged by 609.86% to $702000.0 in 2023, then crashed by 117.52% to -$123000.0 in 2024, then soared by 73.17% to -$33000.0 in 2025.
- Business Quant data shows Capital Expenditures for OPRX at -$33000.0 in Q4 2025, $54000.0 in Q3 2025, and $10000.0 in Q2 2025.